Clinical Outcomes After AcrySof® ReStor IOL Surgery in Faculty Practice at UTSW Medical Center at Dallas: A Retrospective Review
NCT ID: NCT00344578
Last Updated: 2011-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2006-03-31
2007-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ACRYSOF® Restor Apodized Diffractive IOL Postmarket Evaluation of Clinical Outcomes and Life-Style Visual Performance RESTOR IOL SN60WF IOL (Control Group)
NCT00345111
Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric +3
NCT00719732
Visual Function After Implantation of Bilateral AcrySoft ReSTOR Aspheric IOL
NCT00934622
Visual Function Evaluation of Bilateral AcrySof ReSTOR Aspheric IOL
NCT00818116
Contralateral ReSTOR / Monofocal or Phakic Eye
NCT00731640
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The pre-operative and post-operative data from ReSTOR® IOL implant cataract surgeries will be analyzed to determine whether the desired outcome was achieved, i.e. excellent vision with no correction. Variables to be studied include patient age, gender, number of ReSTOR® IOL implants, ocular comorbidities, preoperative and postoperative corrected and uncorrected visual acuities, keratometry readings, and corneal topography readings. A patient survey will also be sent to patients having undergone the surgery to measure their level of satisfaction.
Project Goals: The ultimate outcome of this project is to learn more insight on the following:
1. Visual acuity with and without correction of distance and near at 3-6 months
2. Percent of patients requiring keratorefractive surgery
3. Ocular comorbidity subgroup analysis
4. Monocular implantation subanalysis (prior to LASIK)
5. Comparison of post-op spherical equivalent to target refraction
6. Posterior capsule opacity that may be treated with laser procedure known as a YAG laser capsulotomy?
7. Subjective patient satisfaction
8. Validated questionnaire assessing visual function and quality of life
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Restor IOL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Texas Southwestern Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
UTSW Medical Center at Dallas
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adam Fedyk, MD
Role: PRINCIPAL_INVESTIGATOR
UTSW Medical Center at Dallas
Vinod Mootha, MD
Role: STUDY_DIRECTOR
UTSW Medical Center at Dallas
James McCulley, MD
Role: STUDY_CHAIR
UTSW Medical Center at Dallas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aston Ambulatory Care Center
Dallas, Texas, United States
UTSW Medical Center at Dallas
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Fedyk001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.